To build a strong case, consider the following factors: During a free consultation, our team can evaluate the specifics of your situation and advise you on the strength of your claim
The GLP-1 (glucagon-like peptide-1) hormone is an incretin hormone primarily involved in glucose metabolism and appetite regulation
Setting Yourself Up For Success Sustainable weight management during menopause typically happens gradually, with many women seeing progress in the first few weeks of beginning GLP-1 medication
Any unauthorized use or disclosure is prohibited
Key timing considerations: Morning injection produces peak appetite suppression around mid-afternoon to evening, ideal for those who struggle with afternoon snacking and dinner portions Evening injection produces peak levels overnight and through the morning, beneficial for those who overeat at breakfast or need better fasting glucose control The 13-hour half-life means effects noticeably diminish in the latter half of each 24-hour cycle Consistency is absolutely critical with daily dosing because missed doses create more significant gaps in drug levels Many liraglutide users tie their injection to a specific daily habit (brushing teeth, morning coffee ritual) to prevent missed doses Dulaglutide (weekly injectable) Dosing frequency: Once weekly, same day each week Half-life: approximately 5 days (120 hours) Peak concentration: 24 to 72 hours after injection Recommended timing approach: Similar pharmacokinetic profile to tirzepatide in terms of half-life, though the mechanism is pure GLP-1 agonism
We minimize side effects through gradual dosing and provide management strategies
